Clinical Trials

Phase 3 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT04241185 2024-11-25

MK-3475-992

520 enrolled

Urinary Bladder Neoplasms

NCT03658304 2024-11-05

Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma

29 enrolled 11 charts

Phase 3 Active not recruiting

Carcinoma, Transitional Cell

NCT05243550 2024-11-04

ENVISION

240 enrolled 20 charts 1 FDA

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT00981656 2024-09-19

Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer

37 enrolled 19 charts

Urinary Bladder Neoplasms

NCT05136898 2024-09-19

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

8 enrolled 18 charts

Phase 3 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06462001 2024-06-17

BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer

500 enrolled

Carcinoma, Transitional Cell

NCT04688931 2024-06-06

ATLAS

282 enrolled 29 charts

Phase 2 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06227065 2024-01-26

POLO

28 enrolled

Phase 1 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05979909 2023-08-07

Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma

40 enrolled

Urothelial Carcinoma Ureter

NCT02948543 2023-06-18

BCG+MM

Phase 3 Unknown

501 enrolled

Urinary Bladder Neoplasms

NCT02695771 2023-04-21

BIC

101 enrolled 11 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT03617913 2023-01-06

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

2 enrolled 8 charts

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT03844256 2022-08-12

CRIMI

Phase 1/2 Recruiting

50 enrolled

Urinary Bladder Neoplasms

NCT02316171 2022-07-27

CANON

Phase 1 Completed

16 enrolled 8 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT00318643 2021-10-29

Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer

Phase 1/2 Completed

27 enrolled 14 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT01438112 2021-04-14

BOND

Phase 2/3 Terminated

22 enrolled

Adenoviridae Infections, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Neoplasms, Virus Diseases

NCT02793128 2020-12-22

Olympus

71 enrolled 16 charts 2 FDA

Carcinoma, Carcinoma, Transitional Cell

NCT04006691 2020-05-07

Retreatment

Phase 3 Withdrawn

Carcinoma, Carcinoma, Transitional Cell

NCT03335059 2020-04-15

RITE-USA

5 enrolled

Urinary Bladder Neoplasms, Disease

NCT02982395 2019-08-30

Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC

36 enrolled

Non-Muscle Invasive Bladder Neoplasms, Carcinoma, Transitional Cell

NCT03694535 2018-10-03

Intravesical Thermochemotherapy With Mitomycin-c

Phase NA Completed

44 enrolled

Urinary Bladder Neoplasms, Neoplasms

NCT00974818 2015-11-20

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

50 enrolled 7 charts

Phase EARLY_PHASE1 Completed

Urinary Bladder Neoplasms

NCT00734994 2015-06-29

Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer

15 enrolled 5 charts

Non-Muscle Invasive Bladder Neoplasms

NCT00024349 2013-12-18

Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer

350 enrolled

Urinary Bladder Neoplasms

NCT01094964 2013-08-12

Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer

Phase 3 Unknown

242 enrolled

Urinary Bladder Neoplasms

NCT01920269 2013-08-09

EMDA/MMC

Phase 2/3 Completed

331 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT00023842 2012-09-24

BCG With or Without Mitomycin in Treating Patients With Bladder Cancer

97 enrolled

Urinary Bladder Neoplasms

NCT00042887 2012-09-24

Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer

58 enrolled

Urinary Bladder Neoplasms

NCT01149174 2011-10-04

EMDA/PRE-TUR

352 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT01442519 2011-09-28

BCG/EMDA-MMC

212 enrolled